Arkin Holdings is the largest and leading Israel-based life sciences investor dedicated to empowering companies that create breakthrough pharma, biotech and medical device technologies.
Arkin Holdings has a vision of creating a professional and financial platform.
Arkin Holdings was founded in 2009 by Mori Arkin. The company is headquartered in Tel Aviv, Tel Aviv, Israel.
Arkin Holdings has successfully made strategic investments in a number of private pharma and biotech companies, including public companies Solgel (Nasdaq:SLGL) and Urogen (Nasdaq:URGN) and more than 10 private companies including , cCAM Biotherapeutics , Keros Therapeutics, Censa Pharmaceuticals and Oncorus.
Arkin Holdings has raisd $140M in capital commitments, from Arkin Holdings as well as an investor group including Migdal and Phoenix Group, on Mar 10, 2020.